<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE chapter PUBLIC "-//ES//DTD book DTD version 5.5.0//EN//XML" "book550.dtd" [<!ENTITY f008-001-9780702070280 SYSTEM "f008-001-9780702070280" NDATA IMAGE><!ENTITY f008-002-9780702070280 SYSTEM "f008-002-9780702070280" NDATA IMAGE><!ENTITY icon01-9780702070280 SYSTEM "icon01-9780702070280" NDATA IMAGE><!ENTITY u008-001-9780702070280 SYSTEM "u008-001-9780702070280" NDATA IMAGE><!ENTITY u008-002-9780702070280 SYSTEM "u008-002-9780702070280" NDATA IMAGE><!ENTITY u008-003-9780702070280 SYSTEM "u008-003-9780702070280" NDATA IMAGE><!ENTITY u008-004-9780702070280 SYSTEM "u008-004-9780702070280" NDATA IMAGE>]><chapter docsubtype="chp" id="c00008" version="5.5" xml:lang="en" xmlns="http://www.elsevier.com/xml/bk/dtd" xmlns:ce="http://www.elsevier.com/xml/common/dtd" xmlns:xlink="http://www.w3.org/1999/xlink"><info><ce:pii>B978-0-7020-7028-0.00008-1</ce:pii><ce:doi>10.1016/B978-0-7020-7028-0.00008-1</ce:doi><ce:isbn>978-0-7020-7028-0</ce:isbn><ce:copyright type="full-transfer" year="2018">Elsevier Ltd</ce:copyright></info><ce:floats><ce:figure id="f0030"><ce:label>Fig. 8.1</ce:label><ce:caption id="ca0025"><ce:simple-para id="sp0035" role="title">Sites of action of venoms on the haemostasis system.</ce:simple-para></ce:caption><ce:alt-text id="atte0010" role="short">Fig. 8.1</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:link id="ln0045" locator="f008-001-9780702070280" xlink:href="pii:B9780702070280000081/f008-001-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:figure id="f0035"><ce:label>Fig. 8.2</ce:label><ce:caption id="ca0030"><ce:simple-para id="sp0055" role="title">Principal snake venom neurotoxins acting at the neuromuscular junction (NMJ).</ce:simple-para><ce:simple-para id="sp0060" role="caption">The pre-synaptic neurotoxins (β-bungarotoxin-like) bind to the cell membrane of the terminal axon (1), form a synaptosome (2) and enter the cell, where they disrupt acetylcholine (ACh) production (3) and damage intracellular structures, including ion channels (4). On initial entry, they cause release of excess ACh, followed by cessation of all ACh release, causing irreversible paralysis until the cell is repaired (days to weeks later). The post-synaptic neurotoxins (α-bungarotoxin-like) bind adjacent to the ACh receptor on the external surface of the muscle end plate and block ACh binding (5), thereby ceasing neurotransmission. Because this action is external to the cell and does not cause cell damage, it is potentially a reversible paralysis.</ce:simple-para></ce:caption><ce:alt-text id="atte0015" role="short">Fig. 8.2</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:link id="ln0070" locator="f008-002-9780702070280" xlink:href="pii:B9780702070280000081/f008-002-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure><ce:textbox id="b0010" role="alt1"><ce:label><ce:inline-figure baseline="0.0"><ce:link id="ln0030" locator="icon01-9780702070280" xlink:href="pii:B9780702070280000081/icon01-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/><ce:alt-text id="atte0020" role="short">Image 1</ce:alt-text></ce:inline-figure>8.1</ce:label><ce:alt-text id="atte0025" role="short">8.1</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:textbox-head><ce:title id="tit0015">Key venom effects<ce:cross-ref id="crf0110" refid="fn0010">*</ce:cross-ref><ce:footnote id="fn0010"><ce:label>*</ce:label><ce:note-para id="np0010">All venom components have lethal potential.</ce:note-para></ce:footnote></ce:title></ce:textbox-head><ce:textbox-body><ce:sections><ce:para id="p0130"><ce:display><ce:table frame="topbot" id="t0010"><ce:alt-text id="atte0030" role="short">Unlabelled table</ce:alt-text><tgroup cols="3"><colspec colname="col1" colnum="1"/><colspec colname="col2" colnum="2"/><colspec colname="col3" colnum="3"/><thead><row rowsep="1"><entry align="left">Venom component</entry><entry align="left">Clinical effects</entry><entry align="left">Type of venomous animal</entry></row></thead><tbody><row rowsep="0"><entry align="left"><ce:bold>Neurotoxin</ce:bold></entry><entry align="left"/><entry align="left"/></row><row rowsep="0"><entry align="left">Paralytic</entry><entry align="left">Flaccid paralysis</entry><entry align="left">Some snakes<ce:br/>Paralysis ticks<ce:br/>Cone snails<ce:br/>Blue-ringed octopus</entry></row><row rowsep="1"><entry align="left">Excitatory</entry><entry align="left">Neuroexcitation: autonomic storm, cardiotoxicity, pulmonary oedema</entry><entry align="left">Some scorpions, spiders, jellyfish (irukandji)</entry></row><row rowsep="1"><entry align="left"><ce:bold>Myotoxins</ce:bold></entry><entry align="left">Systemic or local myolysis</entry><entry align="left">Some snakes</entry></row><row rowsep="1"><entry align="left"><ce:bold>Cardiotoxins</ce:bold></entry><entry align="left">Direct or indirect cardiotoxicity; cardiac collapse, shock</entry><entry align="left">Some snakes, scorpions, spiders and jellyfish (box jellyfish)</entry></row><row rowsep="1"><entry align="left"><ce:bold>Haemostasis system toxins</ce:bold></entry><entry align="left">Variation from rapid coagulopathy and bleeding to thrombosis, deep venous thrombosis and pulmonary emboli</entry><entry align="left">Many snakes and a few scorpions (<ce:italic>Hemiscorpius</ce:italic>)<ce:br/>Brazilian caterpillars (<ce:italic>Lonomia</ce:italic>)</entry></row><row rowsep="1"><entry align="left"><ce:bold>Haemorrhagic toxins</ce:bold></entry><entry align="left">Local vessel damage, fluid extravasation, blistering, ecchymosis, shock</entry><entry align="left">Mainly some snakes</entry></row><row rowsep="1"><entry align="left"><ce:bold>Nephrotoxins</ce:bold></entry><entry align="left">Renal damage</entry><entry align="left">Some snakes, massed bee and wasp stings</entry></row><row rowsep="1"><entry align="left"><ce:bold>Necrotoxins</ce:bold></entry><entry align="left">Local tissue injury/necrosis, shock</entry><entry align="left">Some snakes, a few scorpions (<ce:italic>Hemiscorpius</ce:italic>), spiders (recluse spiders), jellyfish and stingrays</entry></row><row><entry align="left"><ce:bold>Allergic toxins</ce:bold></entry><entry align="left">Induction of acute allergic response (direct and indirect)</entry><entry align="left">Almost all venoms but particularly those of social insects (i.e. bees, wasps, ants)</entry></row></tbody></tgroup></ce:table></ce:display></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="b0015" role="alt1"><ce:label><ce:inline-figure baseline="0.0"><ce:link id="ln0035" locator="icon01-9780702070280" xlink:href="pii:B9780702070280000081/icon01-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/><ce:alt-text id="atte0035" role="short">Image 2</ce:alt-text></ce:inline-figure>8.2</ce:label><ce:alt-text id="atte0040" role="short">8.2</ce:alt-text><ce:textbox-head><ce:title id="tit0020">Venomous animals and human envenoming</ce:title></ce:textbox-head><ce:textbox-body><ce:sections><ce:para id="p0140"><ce:display><ce:table frame="topbot" id="t0015"><ce:alt-text id="atte0045" role="short">Unlabelled table</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><tgroup cols="4"><colspec colname="col1" colnum="1"/><colspec colname="col2" colnum="2"/><colspec colname="col3" colnum="3"/><colspec colname="col4" colnum="4"/><thead><row rowsep="1"><entry align="left">Phyla</entry><entry align="left">Principal venomous animal groups</entry><entry align="left">Estimated number of human cases/year</entry><entry align="left">Estimated number of human deaths/year</entry></row></thead><tbody><row><entry morerows="2" rowsep="1" align="left"><ce:bold>Chordata</ce:bold></entry><entry rowsep="0" align="left">Snakes</entry><entry rowsep="0" align="left">&#x003E; 2.5 million</entry><entry rowsep="0" align="left">&#x003E; 100 000</entry></row><row rowsep="0"><entry align="left">Spiny fish</entry><entry align="left">? &#x003E; 100 000</entry><entry align="left">Close to zero</entry></row><row rowsep="1"><entry align="left">Stingrays</entry><entry align="left">? &#x003E; 100 000</entry><entry align="left">? &#x003C; 10</entry></row><row><entry morerows="3" rowsep="1" align="left"><ce:bold>Arthropoda</ce:bold></entry><entry rowsep="0" align="left">Scorpions</entry><entry rowsep="0" align="left">&#x003E; 1 million</entry><entry rowsep="0" align="left">? &#x003C; 5000</entry></row><row rowsep="0"><entry align="left">Spiders</entry><entry align="left">? &#x003E; 100 000</entry><entry align="left">? &#x003C; 100</entry></row><row rowsep="0"><entry align="left">Paralysis ticks</entry><entry align="left">? &#x003E; 1000</entry><entry align="left">? &#x003C; 10</entry></row><row rowsep="1"><entry align="left">Insects</entry><entry align="left">? &#x003E; 1 million</entry><entry align="left">? &#x003E; 1000<ce:cross-ref id="crf0120" refid="tn0010">*</ce:cross-ref></entry></row><row><entry morerows="1" rowsep="1" align="left"><ce:bold>Mollusca</ce:bold></entry><entry rowsep="0" align="left">Cone snails</entry><entry rowsep="0" align="left">? &#x003C; 1000</entry><entry rowsep="0" align="left">? &#x003C; 10</entry></row><row rowsep="1"><entry align="left">Blue-ringed octopus</entry><entry align="left">? &#x003C; 100</entry><entry align="left">? &#x003C; 10</entry></row><row><entry align="left"><ce:bold>Coelenterata</ce:bold></entry><entry align="left">Jellyfish</entry><entry align="left">? &#x003E; 1 million</entry><entry align="left">? &#x003C; 10</entry></row></tbody></tgroup><ce:table-footnote id="tn0010"><ce:label>*</ce:label><ce:note-para id="np0015">Social insect stings cause death by anaphylaxis rather than primary venom toxicity, except for massive multiple sting attacks.</ce:note-para></ce:table-footnote></ce:table></ce:display></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="b0020" role="alt1"><ce:label><ce:inline-figure baseline="0.0"><ce:link id="ln0040" locator="icon01-9780702070280" xlink:href="pii:B9780702070280000081/icon01-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/><ce:alt-text id="atte0050" role="short">Image 3</ce:alt-text></ce:inline-figure>8.3</ce:label><ce:alt-text id="atte0055" role="short">8.3</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:textbox-head><ce:title id="tit0025">Local and systemic effects of envenomation</ce:title></ce:textbox-head><ce:textbox-body><ce:sections><ce:para id="p0160"><ce:display><ce:table frame="topbot" id="t0020"><ce:alt-text id="atte0060" role="short">Unlabelled table</ce:alt-text><tgroup cols="2"><colspec colname="col1" colnum="1"/><colspec colname="col2" colnum="2"/><tbody><row role="thead1" rowsep="0"><entry namest="col1" nameend="col2" align="left"><ce:bold>Local effects</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:list id="ulist0030"><ce:list-item id="u0105"><ce:label>•</ce:label><ce:para id="p0165">Pain</ce:para></ce:list-item><ce:list-item id="u0110"><ce:label>•</ce:label><ce:para id="p0170">Sweating</ce:para></ce:list-item><ce:list-item id="u0115"><ce:label>•</ce:label><ce:para id="p0175">Erythema</ce:para></ce:list-item><ce:list-item id="u0120"><ce:label>•</ce:label><ce:para id="p0180">Major direct tissue trauma (e.g. stingray injuries)</ce:para></ce:list-item></ce:list></entry><entry align="left"><ce:list id="ulist0035"><ce:list-item id="u0125"><ce:label>•</ce:label><ce:para id="p0185">Blistering</ce:para></ce:list-item><ce:list-item id="u0130"><ce:label>•</ce:label><ce:para id="p0190">Necrosis</ce:para></ce:list-item><ce:list-item id="u0135"><ce:label>•</ce:label><ce:para id="p0195">Swelling</ce:para></ce:list-item><ce:list-item id="u0140"><ce:label>•</ce:label><ce:para id="p0200">Bleeding and bruising</ce:para></ce:list-item></ce:list></entry></row><row role="thead1" rowsep="0"><entry namest="col1" nameend="col2" align="left"><ce:bold>Non-specific systemic effects</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:list id="ulist0040"><ce:list-item id="u0145"><ce:label>•</ce:label><ce:para id="p0205">Headache</ce:para></ce:list-item><ce:list-item id="u0150"><ce:label>•</ce:label><ce:para id="p0210">Nausea</ce:para></ce:list-item><ce:list-item id="u0155"><ce:label>•</ce:label><ce:para id="p0215">Vomiting and diarrhoea</ce:para></ce:list-item><ce:list-item id="u0160"><ce:label>•</ce:label><ce:para id="p0220">Abdominal pain</ce:para></ce:list-item><ce:list-item id="u0165"><ce:label>•</ce:label><ce:para id="p0225">Tachycardia or bradycardia</ce:para></ce:list-item><ce:list-item id="u0170"><ce:label>•</ce:label><ce:para id="p0230">Hypertension or hypotension</ce:para></ce:list-item></ce:list></entry><entry align="left"><ce:list id="ulist0045"><ce:list-item id="u0175"><ce:label>•</ce:label><ce:para id="p0235">Pulmonary oedema</ce:para></ce:list-item><ce:list-item id="u0180"><ce:label>•</ce:label><ce:para id="p0240">Dizziness</ce:para></ce:list-item><ce:list-item id="u0185"><ce:label>•</ce:label><ce:para id="p0245">Collapse</ce:para></ce:list-item><ce:list-item id="u0190"><ce:label>•</ce:label><ce:para id="p0250">Convulsions</ce:para></ce:list-item><ce:list-item id="u0195"><ce:label>•</ce:label><ce:para id="p0255">Shock</ce:para></ce:list-item><ce:list-item id="u0200"><ce:label>•</ce:label><ce:para id="p0260">Cardiac arrest</ce:para></ce:list-item></ce:list></entry></row><row role="thead1" rowsep="0"><entry namest="col1" nameend="col2" align="left"><ce:bold>Specific systemic effects</ce:bold></entry></row><row><entry namest="col1" nameend="col2" align="left"><ce:list id="ulist0050"><ce:list-item id="u0205"><ce:label>•</ce:label><ce:para id="p0265">Neurotoxic flaccid paralysis (descending or ascending)</ce:para></ce:list-item><ce:list-item id="u0210"><ce:label>•</ce:label><ce:para id="p0270">Excitatory neurotoxicity (catecholamine storm-like and similar)</ce:para></ce:list-item><ce:list-item id="u0215"><ce:label>•</ce:label><ce:para id="p0275">Rhabdomyolysis (systemic or local)</ce:para></ce:list-item><ce:list-item id="u0220"><ce:label>•</ce:label><ce:para id="p0280">Coagulopathy (procoagulant/fibrinolytic or anticoagulant or thrombotic or antiplatelet)</ce:para></ce:list-item><ce:list-item id="u0225"><ce:label>•</ce:label><ce:para id="p0285">Cardiotoxicity (decreased/abnormal cardiac function or arrhythmia or arrest)</ce:para></ce:list-item><ce:list-item id="u0230"><ce:label>•</ce:label><ce:para id="p0290">Acute kidney injury (polyuria or oliguria or anuria or isolated elevated creatinine/urea)</ce:para></ce:list-item></ce:list></entry></row></tbody></tgroup></ce:table></ce:display></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="b0025" role="alt1"><ce:label><ce:inline-figure baseline="0.0"><ce:link id="ln0050" locator="icon01-9780702070280" xlink:href="pii:B9780702070280000081/icon01-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/><ce:alt-text id="atte0065" role="short">Image 4</ce:alt-text></ce:inline-figure>8.4</ce:label><ce:alt-text id="atte0070" role="short">8.4</ce:alt-text><ce:textbox-head><ce:title id="tit0030">Selected important venomous animals in Asia</ce:title></ce:textbox-head><ce:textbox-body><ce:sections><ce:para id="p0345"><ce:display><ce:table frame="topbot" id="t0025"><ce:alt-text id="atte0075" role="short">Unlabelled table</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><tgroup cols="4"><colspec colname="col1" colnum="1"/><colspec colname="col2" colnum="2"/><colspec colname="col3" colnum="3"/><colspec colname="col4" colnum="4"/><thead><row rowsep="1"><entry align="left">Scientific name<ce:cross-ref id="crf0140" refid="tn0015"><ce:sup loc="post">1</ce:sup></ce:cross-ref></entry><entry align="left">Common name</entry><entry align="left">Clinical effects</entry><entry align="left">Antivenom/antidote/treatment</entry></row></thead><tbody><row role="thead1" rowsep="0"><entry namest="col1" nameend="col4" align="left"><ce:bold>Indian subcontinent</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:italic>Bungarus</ce:italic> spp. (E)</entry><entry align="left">Kraits</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0145" refid="tn0020"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:sup loc="post">,</ce:sup><ce:cross-ref id="crf0150" refid="tn0025"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, myolysis<ce:cross-ref id="crf0155" refid="tn0030"><ce:sup loc="post">4</ce:sup></ce:cross-ref>, hyponatraemia<ce:cross-ref id="crf9000" refid="tn9000"><ce:sup loc="post">5</ce:sup></ce:cross-ref></entry><entry align="left">Indian PV or specific</entry></row><row rowsep="0"><entry align="left"><ce:italic>Naja</ce:italic> spp. (E)</entry><entry align="left">Cobras</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0160" refid="tn0025"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, local necrosis/blistering, shock</entry><entry align="left">Indian PV or specific</entry></row><row rowsep="0"><entry align="left"><ce:italic>Ophiophagus hannah</ce:italic> (E)</entry><entry align="left">King cobra</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0165" refid="tn0025"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, local necrosis, shock</entry><entry align="left">Indian PV or specific</entry></row><row rowsep="0"><entry align="left"><ce:italic>Echis</ce:italic> spp. (Vv)</entry><entry align="left">Saw-scaled vipers</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, renal failure</entry><entry align="left">Indian PV or specific</entry></row><row rowsep="0"><entry align="left"><ce:italic>Daboia russelii</ce:italic> (Vv)</entry><entry align="left">Russell's viper</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, myolysis, renal failure, shock, flaccid paralysis<ce:cross-ref id="crf0170" refid="tn0020"><ce:sup loc="post">2</ce:sup></ce:cross-ref></entry><entry align="left">Indian PV or specific</entry></row><row rowsep="0"><entry align="left"><ce:italic>Hypnale</ce:italic> spp. (Vc)</entry><entry align="left">Hump-nosed vipers</entry><entry align="left">Procoagulant coagulopathy, shock, renal failure</entry><entry align="left">Try Indian PV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Trimeresurus</ce:italic><ce:cross-ref id="crf0175" refid="tn0035"><ce:sup loc="post">6</ce:sup></ce:cross-ref> spp. (Vc)</entry><entry align="left">Green pit vipers</entry><entry align="left">Procoagulant coagulopathy, local necrosis, shock</entry><entry align="left">Indian PV or specific</entry></row><row rowsep="1"><entry align="left"><ce:italic>Hottentotta</ce:italic> spp. (Sc)</entry><entry align="left">Indian scorpions</entry><entry align="left">Neuroexcitation, cardiotoxicity</entry><entry align="left">Indian specific AV<ce:br/>Prazosin</entry></row><row role="thead1" rowsep="0"><entry namest="col1" nameend="col4" align="left"><ce:bold>East Asia</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:italic>Bungarus</ce:italic> spp. (E)</entry><entry align="left">Kraits</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0180" refid="tn0020"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:sup loc="post">,</ce:sup><ce:cross-ref id="crf0185" refid="tn0025"><ce:sup loc="post">3</ce:sup></ce:cross-ref></entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Naja</ce:italic> spp. (E)</entry><entry align="left">Cobras (some spitters)</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0190" refid="tn0025"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, local necrosis/blistering, shock</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Ophiophagus hannah</ce:italic> (E)</entry><entry align="left">King cobra</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0195" refid="tn0025"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, local necrosis, shock</entry><entry align="left">King cobra AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Calloselasma rhodostoma</ce:italic> (Vc)</entry><entry align="left">Malayan pit viper</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, renal failure, shock</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Daboia siamensis</ce:italic> (Vv)</entry><entry align="left">Russell's viper</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, renal failure, shock</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Gloydius</ce:italic> spp. (Vc)</entry><entry align="left">Mamushis, pit vipers</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, shock, renal failure, flaccid paralysis<ce:cross-ref id="crf0200" refid="tn0020"><ce:sup loc="post">2</ce:sup></ce:cross-ref></entry><entry align="left">Specific AV from country</entry></row><row><entry align="left"><ce:italic>Trimeresurus</ce:italic><ce:cross-ref id="crf0205" refid="tn0035"><ce:sup loc="post">6</ce:sup></ce:cross-ref> spp. (Vc)</entry><entry align="left">Green pit vipers, habus</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, shock</entry><entry align="left">Specific AV from country</entry></row></tbody></tgroup><ce:legend><ce:simple-para id="sp0040">(AV = antivenom; PV = polyvalent)</ce:simple-para><ce:simple-para id="sp0045">More information is available from WHO-SEARO <ce:italic>Guidelines for the management of snake-bites</ce:italic> and from <ce:inter-ref id="iw0015" xlink:href="http://toxinology.com">toxinology.com</ce:inter-ref>.</ce:simple-para></ce:legend><ce:table-footnote id="tn0015"><ce:label>1</ce:label><ce:note-para id="np0020">Family names: C = ‘Colubridae’ (mostly ‘non-venomous’; family subject to major taxonomic revisions); E = Elapidae (all venomous); Sc = Scorpionoidea; Vc = Viperidae Crotalinae (New World and Asian vipers); Vv = Viperidae viperinae (Old World vipers).</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0020"><ce:label>2</ce:label><ce:note-para id="np0025">Pre-synaptic.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0025"><ce:label>3</ce:label><ce:note-para id="np0030">Post-synaptic.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0030"><ce:label>4</ce:label><ce:note-para id="np0035">Only reported so far for <ce:italic>B. candidus</ce:italic>, <ce:italic>B. niger</ce:italic> and <ce:italic>B. caeruleus</ce:italic>.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn9000"><ce:label>5</ce:label><ce:note-para id="np9000">Only reported so far for <ce:italic>B. multicinctus</ce:italic> and <ce:italic>B. candidus</ce:italic>.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0035"><ce:label>6</ce:label><ce:note-para id="np0040">Genus is subject to major taxonomic change (split into at least eight genera).</ce:note-para></ce:table-footnote></ce:table></ce:display></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="b0030" role="alt1"><ce:label><ce:inline-figure baseline="0.0"><ce:link id="ln0055" locator="icon01-9780702070280" xlink:href="pii:B9780702070280000081/icon01-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/><ce:alt-text id="atte0080" role="short">Image 5</ce:alt-text></ce:inline-figure>8.5</ce:label><ce:alt-text id="atte0085" role="short">8.5</ce:alt-text><ce:textbox-head><ce:title id="tit0035">Selected important venomous animals in the Americas and Australia</ce:title></ce:textbox-head><ce:textbox-body><ce:sections><ce:para id="p0350"><ce:display><ce:table frame="topbot" id="t0030"><ce:alt-text id="atte0090" role="short">Unlabelled table</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><tgroup cols="4"><colspec colname="col1" colnum="1"/><colspec colname="col2" colnum="2"/><colspec colname="col3" colnum="3"/><colspec colname="col4" colnum="4"/><thead><row rowsep="1"><entry align="left">Scientific name<ce:cross-ref id="crf0210" refid="tn0040"><ce:sup loc="post">1</ce:sup></ce:cross-ref></entry><entry align="left">Common name</entry><entry align="left">Clinical effects</entry><entry align="left">Antivenom/antidote/treatment</entry></row></thead><tbody><row role="thead1" rowsep="0"><entry namest="col1" nameend="col4" align="left"><ce:bold>North America</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:italic>Crotalus</ce:italic> spp. (Vc)</entry><entry align="left">Rattlesnakes</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering (flaccid paralysis<ce:cross-ref id="crf0215" refid="tn0045"><ce:sup loc="post">2</ce:sup></ce:cross-ref> rare), shock</entry><entry align="left">CroFab AV or Bioclon Antivipmyn AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Sistrurus</ce:italic> spp. (Vc)</entry><entry align="left">Massasaugas</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, shock</entry><entry align="left">CroFab AV or Bioclon Antivipmyn AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Agkistrodon</ce:italic> spp. (Vc)</entry><entry align="left">Copperheads and moccasins</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, shock</entry><entry align="left">CroFab AV or Bioclon Antivipmyn AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Micrurus</ce:italic> spp. (E)</entry><entry align="left">Coral snakes</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0220" refid="tn0050"><ce:sup loc="post">3</ce:sup></ce:cross-ref></entry><entry align="left">Bioclon Coralmyn AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Latrodectus mactans</ce:italic></entry><entry align="left">Widow spider</entry><entry align="left">Neuroexcitation</entry><entry align="left">MSD Widow spider AV</entry></row><row rowsep="1"><entry align="left"><ce:italic>Centruroides sculpturatus</ce:italic></entry><entry align="left">Arizona bark scorpion</entry><entry align="left">Neuroexcitation</entry><entry align="left">Bioclon Anascorp AV</entry></row><row role="thead1" rowsep="0"><entry namest="col1" nameend="col4" align="left"><ce:bold>Central and South America</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:italic>Crotalus</ce:italic> spp. (Vc)</entry><entry align="left">Rattlesnakes</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0225" refid="tn0045"><ce:sup loc="post">2</ce:sup></ce:cross-ref>, myolysis, procoagulant coagulopathy, shock, renal failure</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Bothrops</ce:italic> spp. (Vc)</entry><entry align="left">Lancehead vipers</entry><entry align="left">Procoagulant coagulopathy, local necrosis/blistering, shock, renal failure</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Bothriechis</ce:italic> spp. (Vc)</entry><entry align="left">Eyelash pit vipers</entry><entry align="left">Shock, pain and swelling</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Lachesis</ce:italic> spp. (Vc)</entry><entry align="left">Bushmasters</entry><entry align="left">Procoagulant coagulopathy, shock, renal failure, local necrosis/blistering</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Micrurus</ce:italic> spp. (E)</entry><entry align="left">Coral snakes</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0230" refid="tn0045"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:sup loc="post">,</ce:sup><ce:cross-ref id="crf0235" refid="tn0050"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, myolysis, renal failure</entry><entry align="left">Specific AV from country</entry></row><row rowsep="0"><entry align="left"><ce:italic>Tityus serrulatus</ce:italic></entry><entry align="left">Brazilian scorpion</entry><entry align="left">Neuroexcitation, shock</entry><entry align="left">Instituto Butantan scorpion AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Loxosceles</ce:italic> spp.</entry><entry align="left">Recluse spiders</entry><entry align="left">Local necrosis</entry><entry align="left">Instituto Butantan spider AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Phoneutria nigriventer</ce:italic></entry><entry align="left">Banana spider</entry><entry align="left">Neuroexcitation, shock</entry><entry align="left">Instituto Butantan spider AV</entry></row><row rowsep="1"><entry align="left"><ce:italic>Potamotrygon</ce:italic>, <ce:italic>Dasyatis</ce:italic> spp.</entry><entry align="left">Freshwater stingrays</entry><entry align="left">Necrosis of bite area, shock, severe pain and oedema</entry><entry align="left">No available AV; good wound care</entry></row><row role="thead1" rowsep="0"><entry namest="col1" nameend="col4" align="left"><ce:bold>Australia</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:italic>Pseudonaja</ce:italic> spp. (E)</entry><entry align="left">Brown snakes</entry><entry align="left">Procoagulant coagulopathy, renal failure, flaccid paralysis<ce:cross-ref id="crf0240" refid="tn0045"><ce:sup loc="post">2</ce:sup></ce:cross-ref> (rare)</entry><entry align="left">CSL brown snake AV or PVAV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Notechis</ce:italic> spp. (E)</entry><entry align="left">Tiger snakes</entry><entry align="left">Procoagulant coagulopathy, myolysis, flaccid paralysis<ce:cross-ref id="crf0245" refid="tn0045"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:sup loc="post">,</ce:sup><ce:cross-ref id="crf0250" refid="tn0050"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, renal failure</entry><entry align="left">CSL tiger snake AV or PVAV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Oxyuranus</ce:italic> spp. (E)</entry><entry align="left">Taipans</entry><entry align="left">Procoagulant coagulopathy, flaccid paralysis<ce:cross-ref id="crf0255" refid="tn0045"><ce:sup loc="post">2</ce:sup></ce:cross-ref><ce:sup loc="post">,</ce:sup><ce:cross-ref id="crf0260" refid="tn0050"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, myolysis, renal failure</entry><entry align="left">CSL taipan or PVAV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Acanthophis</ce:italic> spp. (E)</entry><entry align="left">Death adders</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0265" refid="tn0050"><ce:sup loc="post">3</ce:sup></ce:cross-ref></entry><entry align="left">CSL death adder or PVAV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Pseudechis</ce:italic> spp.</entry><entry align="left">Black and mulga snakes</entry><entry align="left">Anticoagulant coagulopathy, myolysis, renal failure</entry><entry align="left">CSL black snake AV or PVAV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Enhydrina schistosa</ce:italic></entry><entry align="left">Sea snakes (all species globally)</entry><entry align="left">Flaccid paralysis and/or myolysis</entry><entry align="left">CSL sea snake AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Atrax</ce:italic>, <ce:italic>Hadronyche</ce:italic> spp.</entry><entry align="left">Funnel web spiders</entry><entry align="left">Neuroexcitation, shock</entry><entry align="left">CSL funnel web spider AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Latrodectus hasseltii</ce:italic></entry><entry align="left">Red back spider</entry><entry align="left">Neuroexcitation, pain and sweating</entry><entry align="left">CSL red back spider AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Chironex fleckeri</ce:italic></entry><entry align="left">Box jellyfish</entry><entry align="left">Neuroexcitation, cardiotoxicity, local necrosis</entry><entry align="left">CSL box jellyfish AV</entry></row><row><entry align="left"><ce:italic>Synanceia</ce:italic> spp.</entry><entry align="left">Stonefish</entry><entry align="left">Severe local pain</entry><entry align="left">CSL stonefish AV</entry></row></tbody></tgroup><ce:legend><ce:simple-para id="sp9000">(PVAV = polyvalent antivenom)</ce:simple-para></ce:legend><ce:table-footnote id="tn0040"><ce:label>1</ce:label><ce:note-para id="np0045">For family name, see <ce:cross-ref id="crf0270" refid="b0025">Box 8.4</ce:cross-ref>.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0045"><ce:label>2</ce:label><ce:note-para id="np0050">Pre-synaptic.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0050"><ce:label>3</ce:label><ce:note-para id="np0055">Post-synaptic.</ce:note-para></ce:table-footnote></ce:table></ce:display></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="b0035" role="alt1"><ce:label><ce:inline-figure baseline="0.0"><ce:link id="ln0060" locator="icon01-9780702070280" xlink:href="pii:B9780702070280000081/icon01-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/><ce:alt-text id="atte0095" role="short">Image 6</ce:alt-text></ce:inline-figure>8.6</ce:label><ce:alt-text id="atte0100" role="short">8.6</ce:alt-text><ce:textbox-head><ce:title id="tit0040">Selected important venomous animals in Africa and Europe</ce:title></ce:textbox-head><ce:textbox-body><ce:sections><ce:para id="p0355"><ce:display><ce:table frame="topbot" id="t0035"><ce:alt-text id="atte0105" role="short">Unlabelled table</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><tgroup cols="4"><colspec colname="col1" colnum="1"/><colspec colname="col2" colnum="2"/><colspec colname="col3" colnum="3"/><colspec colname="col4" colnum="4"/><thead><row rowsep="1"><entry align="left">Scientific name<ce:cross-ref id="crf0275" refid="tn0055"><ce:sup loc="post">1</ce:sup></ce:cross-ref></entry><entry align="left">Common name</entry><entry align="left">Clinical effects</entry><entry align="left">Antivenom/antidote/treatment</entry></row></thead><tbody><row role="thead1" rowsep="0"><entry namest="col1" nameend="col4" align="left"><ce:bold>Africa</ce:bold></entry></row><row rowsep="0"><entry morerows="2" align="left"><ce:italic>Naja</ce:italic> spp. (E)</entry><entry align="left">Cobras</entry><entry align="left"/><entry align="left"/></row><row rowsep="0"><entry align="left"><ce:hsp sp="1"/>Non-spitters</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0280" refid="tn0065"><ce:sup loc="post">3</ce:sup></ce:cross-ref> ± local necrosis/blistering</entry><entry align="left">South African PV or Sanofi Pasteur FavAfrica AV</entry></row><row rowsep="0"><entry align="left"><ce:hsp sp="1"/>Spitters</entry><entry align="left">Local necrosis/blistering (flaccid paralysis<ce:cross-ref id="crf0285" refid="tn0065"><ce:sup loc="post">3</ce:sup></ce:cross-ref> uncommon)</entry><entry align="left">South African PV or Sanofi Pasteur FavAfrica AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Dendroaspis</ce:italic> spp. (E)</entry><entry align="left">Mambas</entry><entry align="left">Mamba neurotoxic flaccid paralysis and muscle fasciculation, shock, necrosis (uncommon)</entry><entry align="left">South African PV or Sanofi Pasteur FavAfrica AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Hemachatus haemachatus</ce:italic> (E)</entry><entry align="left">Rinkhals</entry><entry align="left">Flaccid paralysis<ce:cross-ref id="crf0290" refid="tn0065"><ce:sup loc="post">3</ce:sup></ce:cross-ref>, local necrosis, shock</entry><entry align="left">South African PV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Atheris</ce:italic> spp. (Vv)</entry><entry align="left">Bush vipers</entry><entry align="left">Procoagulant coagulopathy, shock, pain and swelling</entry><entry align="left">No available AV (can try South African AV)</entry></row><row rowsep="0"><entry align="left"><ce:italic>Bitis</ce:italic> spp. (Vv)</entry><entry align="left">Puff adders etc.</entry><entry align="left">Procoagulant coagulopathy, shock, cardiotoxicity, local necrosis/blistering</entry><entry align="left">South African PV or Sanofi Pasteur FavAfrica AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Causus</ce:italic> spp. (Vv)</entry><entry align="left">Night adders</entry><entry align="left">Pain and swelling</entry><entry align="left">No available AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Echis</ce:italic> spp. (Vv)</entry><entry align="left">Carpet vipers</entry><entry align="left">Procoagulant coagulopathy, shock, renal failure, local necrosis/blistering</entry><entry align="left">Specific anti-<ce:italic>Echis</ce:italic> AV for species/geographical region or Sanofi Pasteur FavAfrica AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Cerastes</ce:italic> spp. (Vv)</entry><entry align="left">Horned desert vipers</entry><entry align="left">Procoagulant coagulopathy, local necrosis, shock</entry><entry align="left">Specific or polyspecific AV covering <ce:italic>Cerastes</ce:italic> from country of origin</entry></row><row rowsep="0"><entry align="left"><ce:italic>Dispholidus typus</ce:italic> (C)</entry><entry align="left">Boomslang</entry><entry align="left">Procoagulant coagulopathy, shock</entry><entry align="left">Boomslang AV</entry></row><row rowsep="0"><entry align="left"><ce:italic>Androctonus</ce:italic> spp.</entry><entry align="left">North African scorpions</entry><entry align="left">Neuroexcitation</entry><entry align="left">Specific scorpion AV (Algeria, Tunisia, Sanofi Pasteur Scorpifav)</entry></row><row rowsep="1"><entry align="left"><ce:italic>Lelurus quinquestriatus</ce:italic></entry><entry align="left">Yellow scorpion</entry><entry align="left">Neuroexcitation, shock</entry><entry align="left">Specific scorpion AV (Algeria, Tunisia, Sanofi Pasteur Scorpifav)</entry></row><row role="thead1" rowsep="0"><entry namest="col1" nameend="col4" align="left"><ce:bold>Europe</ce:bold></entry></row><row><entry align="left"><ce:italic>Vipera</ce:italic> spp. (Vv)</entry><entry align="left">Vipers and adders</entry><entry align="left">Shock, local necrosis/blistering, procoagulant coagulopathy (flaccid paralysis<ce:cross-ref id="crf0295" refid="tn0060"><ce:sup loc="post">2</ce:sup></ce:cross-ref> rare)</entry><entry align="left">ViperaTab AV or Zagreb AV or SanofiPasteur Viperfav AV</entry></row></tbody></tgroup><ce:legend><ce:simple-para id="sp0050">More information is available from WHO <ce:italic>Guidelines for the prevention and clinical management of snakebite in Africa</ce:italic> and from <ce:inter-ref id="iw0020" xlink:href="http://toxinology.com">toxinology.com</ce:inter-ref>.</ce:simple-para></ce:legend><ce:table-footnote id="tn0055"><ce:label>1</ce:label><ce:note-para id="np0060">For family name, see <ce:cross-ref id="crf0300" refid="b0025">Box 8.4</ce:cross-ref>.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0060"><ce:label>2</ce:label><ce:note-para id="np0065">Pre-synaptic.</ce:note-para></ce:table-footnote><ce:table-footnote id="tn0065"><ce:label>3</ce:label><ce:note-para id="np0070">Post-synaptic.</ce:note-para></ce:table-footnote></ce:table></ce:display></ce:para></ce:sections></ce:textbox-body></ce:textbox><ce:textbox id="b0040" role="alt1"><ce:label><ce:inline-figure baseline="0.0"><ce:link id="ln0065" locator="icon01-9780702070280" xlink:href="pii:B9780702070280000081/icon01-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/><ce:alt-text id="atte0110" role="short">Image 7</ce:alt-text></ce:inline-figure>8.7</ce:label><ce:alt-text id="atte0115" role="short">8.7</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:textbox-head><ce:title id="tit0045">Indications for antivenom</ce:title></ce:textbox-head><ce:textbox-body><ce:sections><ce:para id="p0520"><ce:display><ce:table frame="topbot" id="t0040"><ce:alt-text id="atte0120" role="short">Unlabelled table</ce:alt-text><tgroup cols="2"><colspec colname="col1" colnum="1"/><colspec colname="col2" colnum="2"/><tbody><row role="thead1" rowsep="0"><entry namest="col1" nameend="col2" align="left"><ce:bold>General indications</ce:bold></entry></row><row rowsep="0"><entry align="left"><ce:list id="ulist0075"><ce:list-item id="u0350"><ce:label>•</ce:label><ce:para id="p0525">Shock/cardiac collapse</ce:para></ce:list-item><ce:list-item id="u0355"><ce:label>•</ce:label><ce:para id="p0530">Respiratory compromise</ce:para></ce:list-item><ce:list-item id="u0360"><ce:label>•</ce:label><ce:para id="p0535">Rapidly increasing swelling of the bitten limb</ce:para></ce:list-item></ce:list></entry><entry align="left"><ce:list id="ulist0080"><ce:list-item id="u0365"><ce:label>•</ce:label><ce:para id="p0540">Active bleeding</ce:para></ce:list-item><ce:list-item id="u0370"><ce:label>•</ce:label><ce:para id="p0545">Intractable non-specific symptoms, including recurrent vomiting</ce:para></ce:list-item></ce:list></entry></row><row role="thead1" rowsep="0"><entry namest="col1" nameend="col2" align="left"><ce:bold>Specific indications</ce:bold></entry></row><row><entry align="left"><ce:list id="ulist0085"><ce:list-item id="u0375"><ce:label>•</ce:label><ce:para id="p0550">Developing paralytic features (ptosis etc.)</ce:para></ce:list-item><ce:list-item id="u0380"><ce:label>•</ce:label><ce:para id="p0555">Developing rhabdomyolysis</ce:para></ce:list-item><ce:list-item id="u0385"><ce:label>•</ce:label><ce:para id="p0560">Developing coagulopathy</ce:para></ce:list-item></ce:list></entry><entry align="left"><ce:list id="ulist0090"><ce:list-item id="u0390"><ce:label>•</ce:label><ce:para id="p0565">Developing renal failure</ce:para></ce:list-item><ce:list-item id="u0395"><ce:label>•</ce:label><ce:para id="p0570">Developing neuroexcitatory envenoming</ce:para></ce:list-item></ce:list></entry></row></tbody></tgroup></ce:table></ce:display></ce:para></ce:sections></ce:textbox-body></ce:textbox></ce:floats><ce:label>8</ce:label><ce:title id="tit0010">Envenomation</ce:title><ce:author-group id="aug0010"><ce:author author-id="B9780702070280000081-f50edd3b6ed971195ce80f24eda7a4d9" id="au0010"><ce:given-name>J</ce:given-name><ce:surname>White</ce:surname></ce:author></ce:author-group><outline id="out0010"><ce:list id="ulist0010"><ce:list-item id="u0010"><ce:para id="p0010"><ce:bold>Comprehensive evaluation of the envenomed patient</ce:bold> <ce:cross-ref id="crf0010" refid="s0010"><ce:bold>152</ce:bold></ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0015"><ce:para id="p0015"><ce:bold>Geographical distribution of venomous snakes</ce:bold> <ce:cross-ref id="crf0015" refid="s0020"><ce:bold>153</ce:bold></ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0020"><ce:para id="p0020"><ce:bold>Bedside tests in the envenomed patient</ce:bold> <ce:cross-ref id="crf0020" refid="s0025"><ce:bold>153</ce:bold></ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0025"><ce:para id="p0025"><ce:bold>Overview of envenomation</ce:bold> <ce:cross-ref id="crf0025" refid="s0030"><ce:bold>154</ce:bold></ce:cross-ref><ce:list id="ulist0015"><ce:list-item id="u0030"><ce:para id="p0030">Venom <ce:cross-ref id="crf0030" refid="s0035">154</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0035"><ce:para id="p0035">Venomous animals <ce:cross-ref id="crf0035" refid="s0040">154</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0040"><ce:para id="p0040">Clinical effects <ce:cross-ref id="crf0040" refid="s0045">155</ce:cross-ref></ce:para></ce:list-item></ce:list></ce:para></ce:list-item><ce:list-item id="u0045"><ce:para id="p0045"><ce:bold>General approach to the envenomed patient</ce:bold> <ce:cross-ref id="crf0045" refid="s0065"><ce:bold>156</ce:bold></ce:cross-ref><ce:list id="ulist0020"><ce:list-item id="u0050"><ce:para id="p0050">First aid <ce:cross-ref id="crf0050" refid="s0070">156</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0055"><ce:para id="p0055">Assessment and management in hospital <ce:cross-ref id="crf0055" refid="s0080">158</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0060"><ce:para id="p0060">Treatment <ce:cross-ref id="crf0060" refid="s0100">159</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0065"><ce:para id="p0065">Follow-up <ce:cross-ref id="crf0065" refid="s0115">160</ce:cross-ref></ce:para></ce:list-item></ce:list></ce:para></ce:list-item><ce:list-item id="u0070"><ce:para id="p0070"><ce:bold>Envenomation by specific animals</ce:bold> <ce:cross-ref id="crf0070" refid="s0120"><ce:bold>160</ce:bold></ce:cross-ref><ce:list id="ulist0025"><ce:list-item id="u0075"><ce:para id="p0075">Venomous snakes <ce:cross-ref id="crf0075" refid="s0125">160</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0080"><ce:para id="p0080">Scorpions <ce:cross-ref id="crf0080" refid="s0140">161</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0085"><ce:para id="p0085">Spiders <ce:cross-ref id="crf0085" refid="s0155">161</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0090"><ce:para id="p0090">Paralysis ticks <ce:cross-ref id="crf0090" refid="s0170">161</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0095"><ce:para id="p0095">Venomous insects <ce:cross-ref id="crf0095" refid="s0175">161</ce:cross-ref></ce:para></ce:list-item><ce:list-item id="u0100"><ce:para id="p0100">Marine venomous and poisonous animals <ce:cross-ref id="crf0100" refid="s0190">162</ce:cross-ref></ce:para></ce:list-item></ce:list></ce:para></ce:list-item></ce:list></outline><ce:sections><ce:section id="s0010"><ce:section-title id="st0010">Comprehensive evaluation of the envenomed patient</ce:section-title><ce:para id="p0105"><ce:display><ce:figure id="f0010"><ce:alt-text id="atte0125" role="short">Unlabelled image</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:link id="ln0010" locator="u008-001-9780702070280" xlink:href="pii:B9780702070280000081/u008-001-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure></ce:display></ce:para></ce:section><ce:section id="s0020"><ce:section-title id="st0015">Geographical distribution of venomous snakes</ce:section-title><ce:para id="p0110"><ce:display><ce:figure id="f0015"><ce:caption id="ca0010"><ce:simple-para id="sp0010" role="title">The geographical location of a snakebite determines the likely animal(s) involved and the nature and risks of the envenomation.</ce:simple-para></ce:caption><ce:alt-text id="atte0130" role="short">Unlabelled image</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:link id="ln0015" locator="u008-002-9780702070280" xlink:href="pii:B9780702070280000081/u008-002-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure></ce:display></ce:para></ce:section><ce:section id="s0025"><ce:section-title id="st0020">Bedside tests in the envenomed patient</ce:section-title><ce:para id="p0115"><ce:display><ce:figure id="f0020"><ce:caption id="ca0015"><ce:simple-para id="sp0015" role="title">Examination of urine.</ce:simple-para><ce:simple-para id="sp0020" role="caption">Haematuria may indicate a coagulopathy. Dark urine is suggestive of myoglobinuria, which is a sign of extensive rhabdomyolysis.</ce:simple-para></ce:caption><ce:alt-text id="atte0135" role="short">Unlabelled image</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:link id="ln0020" locator="u008-003-9780702070280" xlink:href="pii:B9780702070280000081/u008-003-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure></ce:display><ce:display><ce:figure id="f0025"><ce:caption id="ca0020"><ce:simple-para id="sp0025" role="title">Twenty-minute whole-blood clotting test (20WBCT).</ce:simple-para><ce:simple-para id="sp0030" role="caption">The presence of coagulopathy is a key indicator of major envenoming for some species. While full laboratory coagulation studies may be the ideal, the 20WBCT has emerged as a simple standardised bedside test of coagulopathy, applicable even in areas with limited health facilities.</ce:simple-para></ce:caption><ce:alt-text id="atte0140" role="short">Unlabelled image</ce:alt-text><ce:source>Copyright © Julian White.</ce:source><ce:link id="ln0025" locator="u008-004-9780702070280" xlink:href="pii:B9780702070280000081/u008-004-9780702070280" xlink:role="http://data.elsevier.com/vocabulary/ElsevierContentTypes/23.4" xlink:type="simple"/></ce:figure></ce:display></ce:para></ce:section><ce:section id="s0030"><ce:section-title id="st0025">Overview of envenomation</ce:section-title><ce:para id="p0120">Envenomation occurs when a venomous animal injects sufficient venom by a bite or a sting into a prey item or perceived predator to cause deleterious local and/or systemic effects. This is defined as a venom-induced disease (VID). Venomous animals generally use their venom to acquire and, in some cases, pre-digest prey, with defensive use a secondary function for many species. Accidental encounters between venomous animals and humans are frequent, particularly in the rural tropics, where millions of cases of venomous bites and stings occur annually. Globally, an increasing number of exotic venomous animals are kept privately, so cases of envenoming may present to hospitals where doctors have insufficient knowledge to manage potentially complex presentations. Doctors everywhere should thus be aware of the basic principles of management of envenomation and how to seek expert support. It is important for doctors to know what types of venomous animal are likely to occur in their geographical area (hospital hinterland; <ce:cross-ref id="crf9005" refid="s0020">p. 153</ce:cross-ref>) and the types of envenoming they may cause.</ce:para><ce:section id="s0035"><ce:section-title id="st0030">Venom</ce:section-title><ce:para id="p0125">Venom is a complex mixture of diverse components (notably toxins), often with several separate toxins that can cause adverse effects in humans, and each is potentially capable of multiple effects (<ce:cross-ref id="crf0105" refid="b0010">Box 8.1</ce:cross-ref><ce:float-anchor refid="b0010"/>). Venom is produced at considerable metabolic cost, so is used sparingly; thus only some bites/stings by venomous animals result in significant envenoming, the remainder being ‘dry bites’. The concept of dry bites is important in understanding approaches to first aid and medical management.</ce:para></ce:section><ce:section id="s0040"><ce:section-title id="st0035">Venomous animals</ce:section-title><ce:para id="p0135">There are many animal groups that contain venomous species (<ce:cross-ref id="crf0115" refid="b0015">Box 8.2</ce:cross-ref><ce:float-anchor refid="b0015"/>). The epidemiological estimates reflect the importance of snakes and scorpions as causes of severe or lethal envenomation, but also the fragmentary nature of the data. For snakes, recent studies have proposed widely varying estimates of epidemiological impact, but even the higher estimates may be too low. A recent comprehensive study in India indicated there are at least 45 000 snakebite-related deaths in that country annually, far above both government figures and previous estimates. In many areas of the poor rural tropics, health resources are limited and few envenoming cases are either seen or recorded within the official hospital system, compared to the actual community burden of disease. While fatal cases may gain most attention, long-term disability from envenomation affects significantly more people and has a major social and economic cost.</ce:para><ce:para id="p0145">Stings by social insects such as bees and wasps may also cause lethal anaphylaxis. Other venomous animals may commonly envenom humans but cause mostly non-lethal effects. A few animals only rarely envenom humans but have a high potential for severe or lethal envenoming. These include box jellyfish, cone snails, blue-ringed octopus, paralysis ticks and Australian funnel web spiders. Within any given group, particularly snakes, there may be a wide range of clinical presentations. Some are described here but for a more detailed discussion of the types of venomous animal, their venoms and their effects on humans, see <ce:inter-ref id="iw0010" xlink:href="http://toxinology.com">toxinology.com</ce:inter-ref>.</ce:para></ce:section><ce:section id="s0045"><ce:section-title id="st0040">Clinical effects</ce:section-title><ce:para id="p0150">With the exception of dry bites, where no significant toxin effects occur, venomous bites/stings can result in three broad classes of effect.</ce:para><ce:section id="s0050"><ce:section-title id="st0045">Local effects</ce:section-title><ce:para id="p0155">These vary from trivial to severe (<ce:cross-ref id="crf0125" refid="b0020">Box 8.3</ce:cross-ref><ce:float-anchor refid="b0020"/>). There may be minimal or no local effects with some snakebites (not even pain), yet lethal systemic envenoming may still be present. For other species, local effects predominate over systemic, and for some, such as certain snakes, both are important (<ce:cross-ref id="crf9010" refid="s0010">p. 152</ce:cross-ref>). Some species commonly cause local necrosis, notably some snakes, brown recluse spiders, an Iranian scorpion (<ce:italic>Hemiscorpius lepturus</ce:italic>) and some stingrays.</ce:para></ce:section><ce:section id="s0055"><ce:section-title id="st0050">General systemic effects</ce:section-title><ce:para id="p0295">By definition, these are non-specific (<ce:cross-ref id="crf0130" refid="b0020">Box 8.3</ce:cross-ref>). Shock is an important complication of major local envenoming by some snake species and, if inadequately treated, can prove lethal, especially in children.</ce:para></ce:section><ce:section id="s0060"><ce:section-title id="st0055">Specific systemic effects</ce:section-title><ce:para id="p0300">These are important in both diagnosis and treatment.<ce:list id="ulist0055"><ce:list-item id="u0235"><ce:label>•</ce:label><ce:para id="p0305"><ce:italic>Neurotoxic flaccid paralysis</ce:italic> can develop very rapidly, progressing from mild weakness to full respiratory paralysis in less than 30 minutes (blue-ringed octopus bite, cone snail sting), or may develop far more slowly, over hours (some snakes) to days (paralysis tick). For neurotoxic snakes, the cranial nerves are usually involved first, with ptosis a common initial sign, often progressing to partial and later complete ophthalmoplegia, fixed dilated pupils, drooling and loss of upper airway protection (<ce:cross-ref id="crf9015" refid="s0010">p. 152</ce:cross-ref>). From this, paralysis may extend to the limbs, with weakness and loss of deep tendon reflexes, the neck (‘broken neck’ sign), then finally respiratory paralysis affecting the diaphragm.</ce:para></ce:list-item><ce:list-item id="u0245"><ce:label>•</ce:label><ce:para id="p0315"><ce:italic>Excitatory neurotoxins</ce:italic> cause an ‘autonomic storm’, often with profuse sweating (<ce:cross-ref id="crf9020" refid="s0010">p. 152</ce:cross-ref>), variable cardiac effects and cardiac failure, sometimes with pulmonary oedema (notably, Australian funnel web spider bite, some scorpions such as Indian red scorpion). This type of envenomation can be rapidly fatal (many scorpions, funnel web spiders), or may cause distressing symptoms but constitute a lesser risk of death (widow spiders, banana spiders).</ce:para></ce:list-item><ce:list-item id="u0250"><ce:label>•</ce:label><ce:para id="p0320"><ce:italic>Myotoxicity</ce:italic> can be localised in the bitten limb, or systemic, affecting mostly skeletal muscles. It can initially be silent, then present with generalised muscle pain, tenderness, myoglobinuria (<ce:cross-ref id="crf9025" refid="s0020">p. 153</ce:cross-ref>) and huge rises in serum creatine kinase (CK). Secondary renal failure can precipitate potentially lethal hyperkalaemic cardiotoxicity.</ce:para></ce:list-item><ce:list-item id="u0255"><ce:label>•</ce:label><ce:para id="p0325"><ce:italic>Cardiotoxicity</ce:italic> is often secondary but symptoms and signs are non-specific in most cases. For some scorpions, envenomation can cause direct cardiac effects, including decreased cardiac output, arrhythmias and pulmonary oedema.</ce:para></ce:list-item><ce:list-item id="u0260"><ce:label>•</ce:label><ce:para id="p0330"><ce:italic>Haemostasis system toxins</ce:italic> cause a variety of effects, depending on the type of toxin (<ce:cross-ref id="crf0135" refid="f0030">Fig. 8.1</ce:cross-ref><ce:float-anchor refid="f0030"/>). Coagulopathy may present as bruising and bleeding from the bite site (<ce:cross-ref id="crf9030" refid="s0010">p. 152</ce:cross-ref>), gums and intravenous sites. Surgical interventions are high-risk in such cases. Other venoms cause thrombosis, usually presenting as deep venous thrombosis (DVT), pulmonary embolus or stroke (particularly Caribbean/Martinique vipers).</ce:para></ce:list-item><ce:list-item id="u0265"><ce:label>•</ce:label><ce:para id="p0335"><ce:italic>Haemorrhagic toxins</ce:italic> cause vascular damage, especially in the bitten limb, with extravasation of fluid and sometimes hypotensive shock; this is a problem associated with some snakebites. The role of these toxins in causing late-developing capillary leak syndrome (<ce:cross-ref id="crf9035" refid="s0010">p. 152</ce:cross-ref>), again associated with some snakebites (notably Russell's viper), is uncertain.</ce:para></ce:list-item><ce:list-item id="u0270"><ce:label>•</ce:label><ce:para id="p0340"><ce:italic>Renal damage</ce:italic> in envenoming is mostly secondary, although some species, such as Russell's vipers, can cause primary renal damage. The presentation is similar in both cases, with changes in urine output (polyuria, oliguria or anuria) or rises in creatinine and urea. In cases with intravascular haemolysis, secondary renal damage is likely. The clinical effects of specific animals in different regions of the world are shown in <ce:cross-refs id="crfs0010" refid="b0025 b0030 b0035">Boxes 8.4–8.6</ce:cross-refs><ce:float-anchor refid="b0025"/><ce:float-anchor refid="b0030"/><ce:float-anchor refid="b0035"/>.</ce:para></ce:list-item></ce:list></ce:para></ce:section></ce:section></ce:section><ce:section id="s0065"><ce:section-title id="st0060">General approach to the envenomed patient</ce:section-title><ce:section id="s0070"><ce:section-title id="st0065">First aid</ce:section-title><ce:para id="p0360">First aid can be crucial in determining the outcome for envenomed patients, yet throughout much of the world inappropriate and dangerous first aid is often administered.</ce:para><ce:para id="p0365">A significant proportion of venom is transported from the bite/sting site via the lymphatic system, particularly for venoms with larger molecular weight toxins, such as many snake venoms. It is recommended that for most forms of envenoming, the patient should be kept still, the bitten limb immobilised with a splint and vital systems supported, where required. A patent upper airway should be specifically ensured and respiratory support provided, if required. For some animals, notably snakes in certain regions, the use of a local pressure pad bandage over the bite site (Myanmar) or a pressure immobilisation bandage (Australia, New Guinea) is recommended.</ce:para><ce:para id="p0370">Ineffective or dangerous first aid, such as suction devices, ‘cut and suck’, local chemicals, snake stones (stones of some sort placed over the snakebite) and tourniquets, should not be used. Tourniquets, in particular, have the potential to cause catastrophic distal limb injuries in snakebite when applied too narrowly or too tightly, or left on too long.</ce:para><ce:section id="s0075"><ce:section-title id="st0070">Transporting patients</ce:section-title><ce:para id="p0375">Where possible, transport should be brought to the patient. It is also vital to obtain medical assessment and intervention at the earliest opportunity, however, so any delay in transporting the patient to a medical facility should be avoided. Severely envenomed patients may develop life-threatening problems, such as shock or respiratory failure, during transport, so ideally the transport method used should allow for management of these problems en route.</ce:para><ce:para id="p0380">In resource-poor environments, simple solutions for rapid transport have been successfully employed, such as motorbikes or similar with the patient supported between the driver in front and another person behind the patient. However, this method cannot cope with a patient developing airway compromise or respiratory failure, such as from developing neurotoxicity.</ce:para></ce:section></ce:section><ce:section id="s0080"><ce:section-title id="st0075">Assessment and management in hospital</ce:section-title><ce:para id="p0385">On arrival at a health station or hospital, there are two immediate priorities:<ce:list id="ulist0060"><ce:list-item id="u0275"><ce:label>•</ce:label><ce:para id="p0390">identifying and treating any life-threatening problems (e.g. circulatory shock, respiratory failure; see <ce:intra-ref id="ii0055" xlink:href="pii:B978-0-7020-7028-0.00016-0#c00016">Ch. 16</ce:intra-ref>)</ce:para></ce:list-item><ce:list-item id="u0280"><ce:label>•</ce:label><ce:para id="p0395">determining whether envenoming is present and if that requires urgent treatment.</ce:para></ce:list-item></ce:list></ce:para><ce:section id="s0085"><ce:section-title id="st0080">Assessment and management of life-threatening problems</ce:section-title><ce:para id="p0400">Patients who are seriously envenomed must be identified early so that appropriate management is not delayed. Critically ill patients must be resuscitated (<ce:intra-ref id="ii0060" xlink:href="pii:B978-0-7020-7028-0.00010-X#s0685">p. 202</ce:intra-ref>) and this takes precedence over administration of any antivenom. Clinicians should look for signs of:<ce:list id="ulist0065"><ce:list-item id="u0285"><ce:label>•</ce:label><ce:para id="p0405">shock/hypotension</ce:para></ce:list-item><ce:list-item id="u0290"><ce:label>•</ce:label><ce:para id="p0410">airway and/or respiratory compromise (likely to be secondary to flaccid paralysis)</ce:para></ce:list-item><ce:list-item id="u0295"><ce:label>•</ce:label><ce:para id="p0415">major bleeding, including internal bleeding (especially intracranial)</ce:para></ce:list-item><ce:list-item id="u0300"><ce:label>•</ce:label><ce:para id="p0420">impending limb compromise from inappropriate first aid (e.g. a tourniquet) – though beware sudden envenoming on removal of a tourniquet.</ce:para></ce:list-item></ce:list></ce:para><ce:para id="p0425">In a patient with severe neurotoxic flaccid paralysis, who is still able to maintain sufficient respiratory function for survival, clinical assessment may suggest irretrievable brain injury (fixed dilated pupils, absent reflexes, no withdrawal response to painful stimuli, no movement of limbs, fixed forward gaze with gross ptosis; <ce:cross-ref id="crf9040" refid="s0010">p. 152</ce:cross-ref>) when, in fact, the patient is conscious.</ce:para></ce:section><ce:section id="s0090"><ce:section-title id="st0085">Assessment for evidence of envenoming</ce:section-title><ce:para id="p0430">As in other areas of medicine, comprehensive assessment of a patient bitten/stung by a venomous animal requires a good history, a careful targeted examination and, where appropriate, ‘laboratory’ testing (though the latter may just consist of simple bedside tests performed by the doctor; <ce:cross-ref id="crf9045" refid="s0020">p. 153</ce:cross-ref>). Animals that are unlikely to cause serious envenomation in humans should be identified so that inappropriate admission and intervention are avoided. Occasionally, patients may be unaware they have been bitten/stung and thus provide a misleading history. In regions of the world where keeping or handling venomous animals is illegal, patients may be reticent in giving a truthful history. Multiple bites or stings are more likely to cause major envenoming.</ce:para><ce:para id="p0435">The following key questions should be asked:<ce:list id="ulist0070"><ce:list-item id="u0305"><ce:label>•</ce:label><ce:para id="p0440">When was the patient exposed to the venomous bite/sting?</ce:para></ce:list-item><ce:list-item id="u0310"><ce:label>•</ce:label><ce:para id="p0445">Was the organism causing it seen and what did it look like (size, colour)?</ce:para></ce:list-item><ce:list-item id="u0315"><ce:label>•</ce:label><ce:para id="p0450">What were the circumstances (on land, in water etc.)?</ce:para></ce:list-item><ce:list-item id="u0320"><ce:label>•</ce:label><ce:para id="p0455">Was there more than one bite/sting?</ce:para></ce:list-item><ce:list-item id="u0325"><ce:label>•</ce:label><ce:para id="p0460">What first aid was used, when and for how long?</ce:para></ce:list-item><ce:list-item id="u0330"><ce:label>•</ce:label><ce:para id="p0465">What symptoms has the patient had (local and systemic)?</ce:para></ce:list-item><ce:list-item id="u0335"><ce:label>•</ce:label><ce:para id="p0470">Are there symptoms suggesting systemic envenoming (paralysis, rhabdomyolysis, coagulopathy etc.)?</ce:para></ce:list-item><ce:list-item id="u0340"><ce:label>•</ce:label><ce:para id="p0475">Is there any significant past medical history and medication use?</ce:para></ce:list-item><ce:list-item id="u0345"><ce:label>•</ce:label><ce:para id="p0480">Is there a past exposure to antivenom/venom and allergies?</ce:para></ce:list-item></ce:list></ce:para><ce:para id="p0485">If patients state that they have been bitten by a particular species, ensure this information is accurate. Private keepers of venomous animals may not have accurate knowledge of what they are keeping, and misidentification of a snake, scorpion or spider can have dire consequences if the wrong antivenom is used.</ce:para><ce:para id="p0490">An outline of some principal findings on examination of the envenomed patient is shown on <ce:cross-ref id="crf9050" refid="s0010">page 152</ce:cross-ref>. The patient may have a cluster of clinical features suggestive of a particular type of envenoming (see <ce:cross-ref id="crf0305" refid="b0010">Box 8.1</ce:cross-ref>).</ce:para><ce:para id="p0495">Even with dangerously venomous animals, some bites/stings will be dry bites and will not require antivenom. The time to onset of first symptoms and signs of envenomation is variable, depending on both animal and patient factors. It may range from a matter of minutes post-bite/sting to 24 hours later in some cases. Therefore, the initial assessment, if normal, must be repeated multiple times during the first 24 hours. Some types of envenomation will not cause symptoms or signs at all, or they may appear very late, long after the optimum time for treatment has passed. Evidence of envenomation may become apparent only through laboratory testing.</ce:para></ce:section><ce:section id="s0095"><ce:section-title id="st0090">Laboratory investigations</ce:section-title><ce:para id="p0500">Specific tests for venom are currently commercially available only for Australian snakebites but are likely to be developed for snakebites in other regions. They are not available for other types of envenomation, where venom concentrations are low. For snakebite, a screen for envenoming includes full blood count, coagulation screen, urea and electrolytes, creatinine, CK and electrocardiogram (ECG). Lung function tests, peripheral oximetry or arterial blood gases may be indicated in cases with potential or established respiratory failure. In areas without access to routine laboratory tests, the 20-minute whole-blood clotting test (20WBCT) is useful (<ce:cross-ref id="crf9055" refid="s0020">p. 153</ce:cross-ref>).</ce:para></ce:section></ce:section><ce:section id="s0100"><ce:section-title id="st0095">Treatment</ce:section-title><ce:para id="p0505">Once a diagnosis of likely envenoming has been made, the next and urgent decision is whether to give antivenom. Antivenom may not be the only crucial treatment, however. For a snakebite by a potentially lethal species such as Russell's viper, the patient might have local effects with oedema, blistering, necrosis, and resultant fluid shifts causing shock, and at the same time have systemic effects such as intractable vomiting, coagulopathy, paralysis and secondary renal failure. Specific treatment with antivenom will be required to reverse the coagulopathy and may prevent worsening of the paralysis and reduce the vomiting, but will not greatly affect the local tissue damage or the renal failure or shock. The latter will require intravenous fluid therapy, possibly respiratory support, renal dialysis and local wound care, perhaps including antibiotics.</ce:para><ce:para id="p0510">Each venomous animal will cause a particular pattern of envenomation, requiring a tailored response. Listing all of these is beyond the scope of this chapter (see ‘<ce:cross-ref id="crf0310" refid="st0175">Further information</ce:cross-ref>’ below).</ce:para><ce:section id="s0105"><ce:section-title id="st0100">Antivenom</ce:section-title><ce:para id="p0515">Antivenom, sometimes inappropriately labelled as ‘anti-snake venom’ (ASV), is the most important tool in treating envenoming. It is made by hyperimmunising an animal, usually horses, to produce antibodies against venom. Once refined, these bind to venom toxins and render them inactive or allow their rapid clearance. Antivenom is available only for certain venomous animals and cannot reverse all types of envenoming. With a few exceptions, it should be given intravenously, with adrenaline (epinephrine) ready in case of anaphylaxis. It should be used only when clearly indicated, and indications will vary between venomous animals (<ce:cross-ref id="crf0315" refid="b0040">Box 8.7</ce:cross-ref><ce:float-anchor refid="b0040"/>). It is critical that the correct antivenom is used at the appropriate dose. Doses vary widely between antivenoms. In some situations (such as the Indian subcontinent), pre-treatment with subcutaneous adrenaline may reduce the chance of anaphylaxis to antivenom.</ce:para><ce:para id="p0575">Antivenom can sometimes reverse post-synaptic neurotoxic paralysis (α-bungarotoxin-like neurotoxins) but will not usually reverse established pre-synaptic paralysis (β-bungarotoxin-like neurotoxins), so should be given before major paralysis has occurred (<ce:cross-ref id="crf0320" refid="f0035">Fig. 8.2</ce:cross-ref><ce:float-anchor refid="f0035"/>). Coagulopathy is best reversed by antivenom, but even after all venom is neutralised, there may be a delay of hours before normal coagulation is restored. More antivenom should not be given because coagulopathy has failed to normalise fully in the first 1–3 hours (except in very particular circumstances). Thrombocytopenia may persist for days, despite antivenom. The role of antivenom in reversing established rhabdomyolysis and renal failure is uncertain. Antivenom may help limit local tissue effects or injury in the bitten limb but this is quite variable and time-dependent. Neuroexcitatory envenoming can respond very well to antivenom (Australian funnel web spider bites and Mexican, South American and Indian scorpion stings) but there is controversy about the effectiveness of antivenom for some species (some North African and Middle Eastern scorpions). The role of antivenom in limiting local venom effects, including necrosis, is also controversial; it is most likely to be effective when given early.</ce:para><ce:para id="p0580">All patients receiving antivenom are at risk of both early and late adverse reactions, including anaphylaxis (early; not always related to immunoglobulin E (IgE)) and serum sickness (late).</ce:para></ce:section><ce:section id="s0110"><ce:section-title id="st0105">Non-antivenom treatments</ce:section-title><ce:para id="p0585">Anticholinesterases are used as an adjunctive treatment for post-synaptic paralysis.</ce:para><ce:para id="p0590">Prazosin (an α-adrenoceptor antagonist) is used in the management of hypertension or pulmonary oedema in scorpion sting cardiotoxicity, particularly for Indian red scorpion stings, though antivenom is now the preferred treatment.</ce:para><ce:para id="p0595">Antibiotics are not routinely required for most bites/stings, though a few animals, such as some South American pit vipers and stingrays, regularly cause significant wound infection or abscess. Tetanus is a risk in some types of bite or sting, such as snakebite, but intramuscular toxoid should not be given until any coagulopathy is reversed.</ce:para><ce:para id="p0600">Mechanical ventilation (<ce:intra-ref id="ii0085" xlink:href="pii:B978-0-7020-7028-0.00010-X#s0685">p. 202</ce:intra-ref>) is vital for established respiratory paralysis that will not reverse with antivenom and may be required for prolonged periods (up to several months in some cases).</ce:para><ce:para id="p0605">Fasciotomy as a treatment for potential compartment syndrome or severe limb swelling is an overused and often disastrous surgical intervention in snakebite and is associated with poor functional outcomes. It should be reserved as a treatment of last resort and be used only in cases where compartment syndrome is confirmed by intracompartment pressure measurement and after first trying limb elevation and antivenom, and ensuring that any coagulopathy has resolved.</ce:para></ce:section></ce:section><ce:section id="s0115"><ce:section-title id="st0110">Follow-up</ce:section-title><ce:para id="p0610">Cases with significant envenomation and those receiving antivenom should be followed up to ensure any complications have resolved and to identify any delayed envenoming.</ce:para></ce:section></ce:section><ce:section id="s0120"><ce:section-title id="st0115">Envenomation by specific animals</ce:section-title><ce:section id="s0125"><ce:section-title id="st0120">Venomous snakes</ce:section-title><ce:para id="p0615">Venomous snakes represent the single most important cause of envenomation globally, affecting millions of humans annually and resulting in large numbers of deaths and patients left with long-term disability. Of the 3000-plus snake species, more than 1000 either are venomous or produce oral toxins. The most important venomous snake families are the Viperidae (vipers; includes typical vipers (subfamily Viperinae) and pit-vipers, with heat-sensing pit organs (subfamily Crotalinae)) and the Elapidae (cobras, kraits, mambas, coral snakes, sea snakes, Australian snakes). However, there are also dangerous species among the Atractaspididae (side-fanged burrowing vipers of Africa and the Middle East) and the non-front-fanged colubrids (NFFC snakes; several families, including the ‘back-fanged’ boomslang and vine snakes of Africa and the keelbacks of Asia).</ce:para><ce:para id="p0620">A selection of important species is included in <ce:cross-refs id="crfs0015" refid="b0025 b0030 b0035">Boxes 8.4–8.6</ce:cross-refs>.</ce:para><ce:section id="s0130"><ce:section id="s0135"><ce:section-title id="st0125">Clinical features and management</ce:section-title><ce:para id="p0625">As with other forms of envenoming, the management of snakebite follows the standard assessment guidelines described previously (<ce:cross-ref id="crf9060" refid="s0010">p. 152</ce:cross-ref>). The nature of the risks posed will depend on the specific snake fauna in a given region (<ce:cross-ref id="crf9065" refid="s0020">p. 153</ce:cross-ref>). For example, in the Indian subcontinent, the major snakebite risks are claimed to come from the ‘big four’: cobras, kraits, Russell's viper and saw-scaled vipers. This list is misleading, though, as it omits other important snakes, including the hump-nosed vipers, king cobra and green pit vipers, all of which can cause severe or lethal envenoming and may not be covered by current Indian antivenoms. Even for those snakes recognised as causing envenoming, there may be major geographical variation in venom and features of envenoming. For Russell's viper (<ce:italic>Daboia</ce:italic> spp.), Sri Lankan specimens can cause rhabdomyolysis and flaccid paralysis, in addition to classic severe coagulopathy, haemorrhage, local bite site injury and acute kidney injury (AKI). Indian populations of the same snake are not associated with either rhabdomyolysis or paralysis, but in parts of Southern India may cause anterior pituitary haemorrhage and/or capillary leak syndrome (hypotensive shock plus vascular leakage resulting in pulmonary oedema). Capillary leak syndrome is also encountered with populations of Burmese Russell's viper (Myanmar), where AKI is especially common and severe.</ce:para><ce:para id="p0630">Antivenom raised against venom from one population of these snakes is often poorly effective against bites from snakes from other regions. Similarly, each of the several species of saw-scaled vipers (<ce:italic>Echis</ce:italic> spp.) spread from West Africa across the Middle East to the Indian subcontinent, including Sri Lanka, has specific venoms that may not be neutralised by antivenoms raised against other species in the genus; Indian antivenoms are ineffective against African species. It follows that, in managing snakebite envenomation, it is critically important to choose the appropriate antivenom and to understand that this may not include every antivenom claiming to cover a given species.</ce:para><ce:para id="p0635">It is unwise to assume that everything is known about envenoming by snakes because new clinical information and syndromes are emerging as more detailed studies are carried out. For instance, krait bites (<ce:italic>Bungarus</ce:italic> spp.), long associated with ‘painless’ bites, later development of devastating flaccid paralysis and a high mortality rate, are now known to have some venom diversity. At least some species can cause rhabdomyolysis and/or severe hyponatraemia, and while bites may be painless, systemic envenomation can cause severe abdominal pain in at least some patients. Among cobra bites, the previous division into ‘non-spitting’, neurotoxic species and ‘spitting’, less neurotoxic species that cause local necrosis is less clear. Non-spitters are now known to spit in parts of their range (e.g. <ce:italic>Naja kaouthia</ce:italic> in West Bengal) and may cause local necrosis in addition to paralysis. Previously clear diagnostic indicators for envenomation by particular types of snakes, such as Russell's vipers and saw-scaled vipers causing coagulopathy, have also become less sure, as it is now known that other snakes, such as hump-nosed vipers (<ce:italic>Hypnale</ce:italic> spp.) and green pit vipers (<ce:italic>Trimeresurus</ce:italic> spp.), found in similar regions, can also cause marked coagulopathy and yet are often not covered by available antivenoms. The ability to cause life-threatening coagulopathy, associated with snakes previously considered harmless, such as the keelbacks in Asia (<ce:italic>Rhabdophis</ce:italic> spp.), can further complicate the diagnostic and management process, as antivenom against these snakes is currently available only in Japan.</ce:para></ce:section></ce:section></ce:section><ce:section id="s0140"><ce:section-title id="st0130">Scorpions</ce:section-title><ce:para id="p0640">Scorpions are second only to snakes in their venomous impact on humankind. Most medically important scorpions are in the family Buthidae and have complex neuroexcitatory venoms with highly specific ion-channel toxins. Classically, stings by these scorpions (some key genera listed in <ce:cross-refs id="crfs0020" refid="b0025 b0030 b0035">Boxes 8.4–8.6</ce:cross-refs>) cause moderate to severe local pain and rapid-onset systemic envenoming with development of a catecholamine storm-like syndrome as the toxins target the nervous system. There may be tachycardia or bradycardia, hyper- or hypotension, profuse sweating, salivation, cardiac dysfunction and pulmonary oedema. Cardiac collapse can occur, especially in children. Other clinical features may vary, depending on the scorpion species.</ce:para><ce:para id="p0645">The Iranian scorpion, <ce:italic>Hemiscorpius lepturus</ce:italic> (principally south-west Iran), causes a quite different presentation, with an initial minor sting, followed by progressive development of bite site or limb necrosis and a potentially lethal systemic envenoming, characterised by intravascular haemolysis, disseminated intravascular coagulation (DIC), secondary renal failure and shock.</ce:para><ce:section id="s0145"><ce:section id="s0150"><ce:section-title id="st0135">Clinical features and management</ce:section-title><ce:para id="p0650">The approach to management varies with species and region. In Latin America, specific antivenoms are routinely used and associated with improved outcomes and dramatic falls in mortality rate. In India, the past reliance on prazosin has been replaced with use of specific antivenom, again with improved outcomes. In contrast, in parts of North Africa, past reliance on antivenom has been replaced with use of cardiac support and arguably poorer outcomes.</ce:para><ce:para id="p0655">In Iran, <ce:italic>H. lepturus</ce:italic> stings are treated with antivenom, though as presentation is often delayed because the sting initially appears to be minor, the role of late antivenom is unclear.</ce:para></ce:section></ce:section></ce:section><ce:section id="s0155"><ce:section-title id="st0140">Spiders</ce:section-title><ce:para id="p0660">There are vast numbers and great species diversity of spiders, with two broad taxonomic groupings: the more ‘primitive’ Mygalomorphs (several medically important species, especially Australian funnel web spiders (<ce:italic>Atrax, Hadronyche</ce:italic> and <ce:italic>Illawarra</ce:italic>)) and the far more diverse Araneomorphs (main clinically important species in the genera <ce:italic>Latrodectus</ce:italic> (widow spiders), <ce:italic>Loxosceles</ce:italic> (brown recluse spiders) and <ce:italic>Phoneutria</ce:italic> (banana or wandering spiders)).</ce:para><ce:section id="s0160"><ce:section id="s0165"><ce:section-title id="st0145">Clinical features and management</ce:section-title><ce:para id="p0665">While spiders and spider bites are common, only those genera noted above commonly cause medically significant effects. In most cases this is a neuroexcitatory envenoming, sometimes similar to severe scorpion envenoming (notable from Australian funnel web spiders), but the recluse spiders cause an often painless bite that develops into local skin necrosis and sometimes a systemic illness similar to that caused by the Iranian scorpion, <ce:italic>H. lepturus</ce:italic>, and with similar lethal potential.</ce:para><ce:para id="p0670">For most of these spiders, antivenom remains the key treatment and is life-saving in some cases. Recent studies suggesting that anti-<ce:italic>Latrodectus</ce:italic> antivenom is ineffective have not been confirmed by independent studies and are in contrast to decades of positive clinical experience.</ce:para></ce:section></ce:section></ce:section><ce:section id="s0170"><ce:section-title id="st0150">Paralysis ticks</ce:section-title><ce:para id="p0675">Most ticks are vectors for disease but a few species in Australia, North America and parts of Africa can cause flaccid paralysis. Toxins in the saliva act as potent pre-synaptic neurotoxins that can cause gradual-onset ascending flaccid paralysis.</ce:para><ce:para id="p0680">There are no antivenoms for tick paralysis. Treatment is based on removal of all ticks and supportive care, including intubation/ventilation where required. The paralysis usually resolves by about 48 hours following removal of all ticks.</ce:para></ce:section><ce:section id="s0175"><ce:section-title id="st0155">Venomous insects</ce:section-title><ce:para id="p0685">A number of insects are venomous but very few cause significant envenoming in humans.</ce:para><ce:section id="s0180"><ce:section-title id="st0160">Venomous lepidopterans</ce:section-title><ce:para id="p0690">The <ce:italic>Lonomia</ce:italic> caterpillars of South America, especially Brazil, have numerous protective venomous spines that, on contact with the skin, can discharge a potent procoagulant venom that can cause a progressive and sometimes fatal consumptive coagulopathy, with terminal haemorrhagic and/or organ failure events. Treatment includes use of a Brazilian specific antivenom and supportive care.</ce:para></ce:section><ce:section id="s0185"><ce:section-title id="st0165">Venomous hymenopterans</ce:section-title><ce:para id="p0695">Many bees, wasps, hornets and some ants have modified ovipositors in the abdomen that act as stings, attached to venom glands. The quantity of venom injected in a single sting is insufficient to cause significant envenomation, but as many of these venoms are potently allergenic, it can cause severe and sometimes fatal anaphylaxis in sensitised persons (<ce:intra-ref id="ii0100" xlink:href="pii:B978-0-7020-7028-0.00004-4#s0265">p. 75</ce:intra-ref>). Massed stings by hundreds of these insects in a swarm, however, can cause life-threatening systemic envenoming, often with intravascular haemolysis, DIC, shock and multi-organ failure. ‘Africanised’ bees are a particular risk for such attacks in South America and now in parts of North America. The giant wasps and hornets of Asia can similarly cause systemic envenoming with multiple attacks. Invasive ants, such as <ce:italic>Solenopsis</ce:italic> spp., are colonising new regions and can cause both allergic reactions and unpleasant local reactions.</ce:para></ce:section></ce:section><ce:section id="s0190"><ce:section-title id="st0170">Marine venomous and poisonous animals</ce:section-title><ce:para id="p0700">The marine environment is dominated by animal life, and many species utilise toxins, either self-produced or taken up from the environment, to arm themselves for either defence or predation. Many of these animals can cause adverse effects in humans, either as a direct venom effect on bites/stings (venomous spiny fish, sea snakes, stingrays, jellyfish, sea urchins, some starfish, cone snails, selected octopuses etc.), or through poisoning if eaten (fugu, ciguatera, scombroid, several types of shellfish poisoning; <ce:intra-ref id="ii0105" xlink:href="pii:B978-0-7020-7028-0.00007-X#s0485">p. 149</ce:intra-ref>).</ce:para><ce:para id="p0705">For venomous marine animals, there is antivenom available only for sea snakes, which can cause rhabdomyolysis and/paralytic neurotoxicity; box jellyfish, which can cause very rapid cardiac collapse; and stonefish, which cause intense sting-site pain. In general, marine venoms respond to heat; thus a hot water immersion or shower (about 45°C) is effective at reducing local pain, particularly for jellyfish, stinging fish and stingray stings. For stingray stings, the venom may cause local tissue damage both through sting trauma and a venom effect; wounds penetrating the abdomen or chest are potentially lethal and wounds should be adequately explored, cleaned and allowed to heal by secondary intention. For bites by the blue-ringed octopus and stings by cone snails, rapid-acting venom can cause early cardiovascular collapse and flaccid paralysis. Supportive care is crucial in ensuring survival from these potentially lethal and seemingly trivial local wounds. Sea urchin and venomous starfish wounds can result in multiple penetrating spines, which cause pain and act as a nidus for secondary infection, but surgical removal of spines can be difficult and unrewarding.</ce:para></ce:section></ce:section></ce:sections><ce:further-reading id="fr0010"><ce:section-title id="st0175">Further information</ce:section-title><ce:further-reading-sec id="fs0010"><ce:section-title id="st0180">Books and journal articles</ce:section-title><ce:bib-reference id="bib1"><ce:label>Meier, White, 1995</ce:label><sb:reference id="sr0010"><sb:contribution langtype="en"><sb:authors><sb:author><ce:given-name>J</ce:given-name><ce:surname>Meier</ce:surname></sb:author><sb:author><ce:given-name>J</ce:given-name><ce:surname>White</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Handbook of clinical toxicology of animal venoms and poisons</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>1995</sb:date><sb:publisher><sb:name>CRC Press</sb:name><sb:location>Boca Raton</sb:location></sb:publisher></sb:book></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib2"><ce:label>World Health Organisation, Regional Office for Africa, 2010</ce:label><sb:reference id="sr0015"><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>World Health Organisation, Regional Office for Africa</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Guidelines for the prevention and clinical management of snakebite in Africa</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>2010</sb:date></sb:book></sb:host><sb:host><sb:e-host><ce:inter-ref id="iw0025" xlink:href="http://afro.who.int">afro.who.int</ce:inter-ref></sb:e-host></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib3"><ce:label>World Health Organisation, Regional Office for South-East Asia, 2010</ce:label><sb:reference id="sr0020"><sb:contribution langtype="en"><sb:authors><sb:author><ce:surname>World Health Organisation, Regional Office for South-East Asia</ce:surname></sb:author></sb:authors><sb:title><sb:maintitle>Guidelines for the management of snake-bites</sb:maintitle></sb:title></sb:contribution><sb:host><sb:book><sb:date>2010</sb:date></sb:book></sb:host><sb:host><sb:e-host><ce:inter-ref id="iw0030" xlink:href="http://searo.who.int">searo.who.int</ce:inter-ref></sb:e-host></sb:host></sb:reference></ce:bib-reference></ce:further-reading-sec><ce:further-reading-sec id="fs0015"><ce:section-title id="st0185">Websites</ce:section-title><ce:bib-reference id="bib4"><ce:label>,</ce:label><sb:reference id="sr0025"><sb:host><sb:e-host><ce:inter-ref id="iw0035" xlink:href="http://toxinology.com">toxinology.com</ce:inter-ref></sb:e-host></sb:host></sb:reference></ce:bib-reference><ce:bib-reference id="bib5"><ce:label>,</ce:label><ce:note><ce:simple-para id="sp0065"><ce:italic>Clinical toxinology guide from the University of Adelaide.</ce:italic></ce:simple-para></ce:note></ce:bib-reference></ce:further-reading-sec></ce:further-reading></chapter>